BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $644,740 | -56.0% | 1,400,000 | -44.0% | 0.15% | -23.9% |
| Q3 2022 | $1,466,000 | +6.1% | 2,500,000 | 0.0% | 0.20% | +22.6% |
| Q2 2022 | $1,382,000 | -48.4% | 2,500,000 | -44.4% | 0.16% | -46.2% |
| Q1 2022 | $2,676,000 | -18.0% | 4,500,000 | 0.0% | 0.30% | -26.5% |
| Q4 2021 | $3,262,000 | -47.5% | 4,500,000 | 0.0% | 0.42% | -47.3% |
| Q3 2021 | $6,219,000 | – | 4,500,000 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |